Rufinamide is a Oral Suspension in the Human Prescription Drug category. It is labeled and distributed by Bionpharma Inc.. The primary component is Rufinamide.
| Product ID | 69452-223_98bd1b77-c7fb-9921-e053-2995a90a1359 |
| NDC | 69452-223 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Rufinamide |
| Generic Name | Rufinamide |
| Dosage Form | Suspension |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-12-19 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA211388 |
| Labeler Name | Bionpharma Inc. |
| Substance Name | RUFINAMIDE |
| Active Ingredient Strength | 40 mg/mL |
| NDC Exclude Flag | N |
| Listing Certified Through | 2020-12-31 |
| Marketing Start Date | 2020-11-06 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA211388 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2018-12-19 |
| Marketing End Date | 2018-12-19 |
| Ingredient | Strength |
|---|---|
| RUFINAMIDE | 40 mg/mL |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0425 | Rufinamide | Rufinamide |
| 0054-0426 | Rufinamide | Rufinamide |
| 0054-0528 | Rufinamide | Rufinamide |
| 0378-2330 | Rufinamide | rufinamide |
| 0378-2331 | Rufinamide | rufinamide |
| 31722-598 | Rufinamide | Rufinamide |
| 31722-599 | Rufinamide | Rufinamide |
| 59651-563 | RUFINAMIDE | RUFINAMIDE |
| 60687-643 | Rufinamide | Rufinamide |
| 67877-673 | Rufinamide | Rufinamide |
| 68180-797 | Rufinamide | Rufinamide |
| 68180-802 | RUFINAMIDE | rufinamide |
| 68180-803 | RUFINAMIDE | rufinamide |
| 69452-223 | Rufinamide | Rufinamide |
| 62856-582 | Banzel | rufinamide |
| 62856-583 | Banzel | rufinamide |
| 62856-584 | Banzel | rufinamide |